| __timestamp | Insmed Incorporated | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 56292000 | 13673000 |
| Thursday, January 1, 2015 | 74277000 | 14358000 |
| Friday, January 1, 2016 | 122721000 | 12203000 |
| Sunday, January 1, 2017 | 109749000 | 18125000 |
| Monday, January 1, 2018 | 145283000 | 17071000 |
| Tuesday, January 1, 2019 | 131711000 | 20018000 |
| Wednesday, January 1, 2020 | 181157000 | 32788000 |
| Friday, January 1, 2021 | 272744000 | 44966000 |
| Saturday, January 1, 2022 | 397518000 | 311681000 |
| Sunday, January 1, 2023 | 571011000 | 77707000 |
In pursuit of knowledge
In the ever-evolving landscape of biotechnology, research and development (R&D) investments are the lifeblood of innovation. Over the past decade, Insmed Incorporated and Lantheus Holdings, Inc. have demonstrated contrasting strategies in their R&D expenditures. Insmed's commitment to innovation is evident, with a staggering 910% increase in R&D spending from 2014 to 2023. This surge underscores their relentless pursuit of groundbreaking therapies. In contrast, Lantheus Holdings, Inc. has maintained a more conservative approach, with a modest 470% increase over the same period. Notably, in 2022, Lantheus made a significant leap, investing nearly 400% more than their 2014 levels, signaling a strategic pivot. As these companies navigate the competitive biotech arena, their R&D investments will continue to shape their trajectories and impact the future of healthcare.
Who Prioritizes Innovation? R&D Spending Compared for Merck & Co., Inc. and Insmed Incorporated
R&D Spending Showdown: Amgen Inc. vs Lantheus Holdings, Inc.
Gilead Sciences, Inc. vs Insmed Incorporated: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Alnylam Pharmaceuticals, Inc. and Lantheus Holdings, Inc.
Research and Development Expenses Breakdown: Viatris Inc. vs Insmed Incorporated
Analyzing R&D Budgets: Insmed Incorporated vs Sarepta Therapeutics, Inc.
Comparing Innovation Spending: Insmed Incorporated and Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc.
Lantheus Holdings, Inc. or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Lantheus Holdings, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Spending Showdown: Lantheus Holdings, Inc. vs MiMedx Group, Inc.